TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro
Qing‐Qing Duan(Sichuan University), Yong‐Ping Chen(Sichuan University)
Cited by 39
Related Papers
Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease
|Journal of Neurology Neurosurgery & Psychiatry|2023|150